Not finding it? Sign in to also search OpenAlex live.
-
LB0010 INHIBITION OF STRUCTURAL DAMAGE PROGRESSION WITH GUSELKUMAB, A SELECTIVE IL-23i, IN PARTICIPANTS WITH ACTIVE PsA: RESULTS THROUGH WEEK 24 OF THE PHASE 3b, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED APEX STUDY2025 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Philip J. Mease, Christopher T. Ritchlin, Laura C. Coates, A. Kollmeier, Bin Zhou, Y. Jiang, +4 more
3citations -
OP25 Efficacy of filgotinib in patients with Ulcerative Colitis by line of therapy in the phase 2b/3 SELECTION trial2021 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease
Laurent Peyrin‐Biroulet, Iris Dotan, Toshifumi Hibi∥, Virginia Taliadouros, Alessandra Faria Oortwijn, Sally Zhao, +3 more
2citations -
TGF-β and PD-L1 inhibition combined with definitive chemoradiotherapy in esophageal squamous cell carcinoma: A phase II clinical trial (NCT04595149).2021 Journal of Clinical Oncology conference-abstract Medicine Esophageal Cancer Research and Treatment
Linde M. Veen, Maarten C.C.M. Hulshof, Connie R. Jiménez, Edwin P. J. G. Cuppen, Laurens Victor Beerepoot, Geert‐Jan Creemers, +9 more
2citations -
P1149 Guselkumab improves health-related quality of life as measured by PROMIS-29 in participants with moderately to severely active Crohn’s disease: Phase 3 GRAVITI study2025 Journal of Crohn s and Colitis conference-abstract Medicine Inflammatory Bowel Disease Open access
Bruce E. Sands, Silvio Danese, Qian Cao, Flávio Steinwurz, Jarosław Kierkuś, Chenglong Han, +5 more
0citations -
POS0920 BIMEKIZUMAB DEMONSTRATES COMPARABLE ONE-YEAR EFFICACY IN MALE AND FEMALE PATIENTS WITH AXIAL SPONDYLOARTHRITIS: RESULTS FROM TWO PHASE 3 STUDIES2025 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Martín Rudwaleit, Sofía Ramiro, Denis Poddubnyy, M. Magrey, Irene E. van der Horst-Bruinsma, Atul A. Deodhar, +4 more
0citations -
POS0900 BIMEKIZUMAB MAINTAINED STRINGENT CLINICAL RESPONSES OVER 2 YEARS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: RESULTS FROM TWO PHASE 3 STUDIES2025 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Florian Proft, Désirée M F M van der Heijde, Sergio Schwartzman, Joerg Ermann, Alexander Marten, Ute Massow, +6 more
0citations -
The VLT/ERIS grating vector Apodizing Phase Plate coronagraph2026 Springer Link (Chiba Institute of Technology) article Physics and Astronomy Adaptive optics and wavefront sensing Open access
Matthew A. Kenworthy, Felix Dannert, Jean Hayoz, David S. Doelman, Ben J. Sutlieff, Frans Snik, +25 more
0citations -
P0670 Efficacy of subcutaneous guselkumab induction therapy by baseline demographics and concomitant medications in participants with moderately to severely active Crohn’s disease: Results from the phase 3 GRAVITI study2025 Journal of Crohn s and Colitis conference-abstract Medicine Inflammatory Bowel Disease Open access
Ailsa L Hart, Tadakazu Hisamatsu, Flávio Steinwurz, Geert D’Haens, Wei Yong Liu, Mobolaji Olurinde, +6 more
0citations -
P0843 Efficacy by baseline disease characteristics of subcutaneous guselkumab induction therapy in patients with moderately to severely active Crohn’s disease: Results at Week 12 from the phase 3 GRAVITI study
Geert D’Haens, Flávio Steinwurz, Ailsa L Hart, Wei Yong Liu, Mobolaji Olurinde, P Ngqawa, +5 more
0citations -
POS0893 EFFICACY OF SECUKINUMAB ACROSS THE AXIAL SPONDYLOARTHRITIS SPECTRUM AMONG PATIENTS GROUPED BY AGE (≥40 YEARS VS <40): A POST HOC ANALYSIS OF 6 PHASE 3 TRIALS2025 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Sofía Ramiro, Corine Gaillez, Uta Kiltz, Lianne S. Gensler, Chaitali Babanrao Pisal, J. Braun, +1 more
0citations -
Correction: Designing integrated early-phase protocols to reduce substantial modifications, including considerations for patient cohorts – a multi-stakeholder consensus view for a practical approach in Germany2026 Frontiers in Pharmacology erratum Mathematics Statistical Methods in Clinical Trials Open access
Robert Schultz-Heienbrok, S. Baumann, R. Böhm, Andreas Bonertz, K. Breithaupt-Groegler, U. Buckpesch-Heberer, +13 more
0citations